Supported by

Left main and multivessel disease

Find all the latest content on left main and multivessel disease published on this website.

The left main coronary artery provides the primary source of blood flow to the left ventricle. Diseases affecting the left main, by itself or in combination with multivessel disease, place the patient at significant risk for life-threatening cardiovascular events. Treatment requires an understanding of all available tools, devices and techniques, like those employed in invasive imaging and functional assessment, as well as taking into account underlying comorbidities such as diabetes. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks. Use the filters below to access PCRonline resources.

Filtered By
Left main and multivessel disease

422 results

Update on coronary physiology in 2024

17 May 2024 – From EuroPCR 2024

This session provides an update on the available options for invasive coronary physiology in 2024. It reviews the latest evidence supporting the clinical adoption of invasive physiology indexes and shares practical tips and tricks for their application. Topics covered include CT-based physiology, pressure wire-based physiology, angiography-based...

Update on coronary physiology in 2024

Management of PCI complications - Part 2

17 May 2024 – From EuroPCR 2024

This session focuses on the management of various PCI complications, including iatrogenic dissection after diagnostic coronary angiography, sinus node artery occlusion, a stuck 6F guide in the axillary artery, and the retrieval of a broken balloon. The session features a series of case presentations and discussions,...

Mastering PCI Complications - Part 2

ACS: how to approach special clinical scenarios

17 May 2024 – From EuroPCR 2024

This session focuses on the management of acute coronary syndrome (ACS) in special clinical scenarios. It covers topics such as treating ACS with multivessel disease, managing an ACS and unstable patient, and addressing subacute myocardial infarction. The session features case presentations and discussions, providing insights and...

ACS: how to approach special clinical scenarios

PCI of bifurcation lesions: management of complications - Part 2

17 May 2024 – From EuroPCR 2024

This session features selected EuroPCR 2024 clinical case submissions showcasing the management of complications during PCI of bifurcation lesions. Cases cover topics such as navigating tricky ostial lesions, dealing with dissecting hematomas, undeflatable balloons, and distal left main perforations. Discussions focus on troubleshooting techniques and optimizing...

PCI of bifurcation lesions: management of complications - Part 2

PCI of bifurcation lesions: management of complications - Part 3

17 May 2024 – From EuroPCR 2024

This session features additional selected EuroPCR 2024 clinical case submissions focusing on the management of complications during PCI of bifurcation lesions. Cases cover topics such as iatrogenic left main endarterectomy, left main dissections, and unexpected complications during various bifurcation stenting techniques. Discussions emphasize the importance of...

PCI of bifurcation lesions: management of complications - Part 3

Mastering the recovery of lost stents in PCI

17 May 2024 – From EuroPCR 2024

This session, comprising selected EuroPCR 2024 Clinical Case submissions, focuses on the management of lost stents during Percutaneous Coronary Intervention (PCI). Participants will explore various cases of stent dislodgement, entrapment, and retrieval challenges, and learn about the corresponding bailout techniques and solutions to preserve coronary flow...

Mastering the recovery of lost stents in PCI

Scientific highlights, clinical trial updates and key learnings from EuroPCR 2024

17 May 2024 – From EuroPCR 2024

Davide Capodanno presents notable trial updates, coronary devices, and key takeaways from EuroPCR 2024. Highlights include the SOLVE-TAVI and IDEAL-LM trials at 5 years, BIOADAPTOR at 2 years, advancements in drug-coated balloons and DES, as well as insights from REC-CAGEFREE II, LANDMARK, and NOTION-2.

References

  • SOLVE-TAVI: Feistritzer HJ, et al....
EuroPCR 2024 Scientific highlights, clinical trial updates and key learnings

Imaging-guided left main PCI - LIVE case

17 May 2024 – From EuroPCR 2024

A 53-year-old male with a history of advanced malignancy (lung adenoma) and mid LAD PCI last year, along with multiple risk factors (hypertension, dyslipidemia, diabetes, and smoking), presented with angina and a positive stress test and CT. The angiography and CT showed significant left main stenosis...

Imaging-guided left main PCI

PCI to treat the bystander disease in STEMI patients: who, when and how?

16 May 2024 – From EuroPCR 2024

Watch this case-based session on PCI for STEMI to see how the guidelines are influenced by the COMPLETE trial. Learn why and how physiology can guide intermediate lesions, the importance of intracoronary imaging guidance, the value of complete revascularization in STEMI patients, the optimal method for...

PCI to treat the bystander disease in STEMI patients: who, when and how?

How to solve tricky coronary complications

16 May 2024 – From EuroPCR 2024

From balloon rupture during double-kissing crush stenting to a successful bailout for delayed coronary obstruction post-TAVI, and an unforeseen complication after chimney stenting in a high-risk patient, the session covers it all. Learn about the nuclear mushroom phenomenon during PCI in a calcified LAD, strategies for...

How to solve tricky coronary complications